Immunoclin (Immunoclin) Total Equity : $17.55 Mil (As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Total Equity?

Immunoclin's total equity for the quarter that ended in Oct. 2014 was $17.55 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Immunoclin Total Equity Historical Data

The historical data trend for Immunoclin's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Total Equity Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

Total Equity

-0.08

-0.31

20.31

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
Total Equity	Get a 7-Day Free Trial									0.53	0.46	19.06	18.05	17.55

Immunoclin Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Immunoclin's Total Equity for the fiscal year that ended in Jan. 2014 is calculated as

Total Equity	=	Total Assets(Q: Jan. 2014 )	-	Total Liabilities(Q: Jan. 2014 )
	=	21.039	-	0.725
	=	20.31

Immunoclin's Total Equity for the quarter that ended in Oct. 2014 is calculated as

Total Equity	=	Total Assets(Q: Oct. 2014 )	-	Total Liabilities(Q: Oct. 2014 )
	=	20.391	-	2.84
	=	17.55

Immunoclin Total Equity Related Terms

Thank you for viewing the detailed overview of Immunoclin's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines